4D Molecular Therapeutics, Inc. (FDMT)
USD 2.78
(5.7%)
USD 2.78
(5.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 20.72 Million | 3.12 Million | 18.03 Million | 13.61 Million | 6.98 Million | 14.13 Million |
| Cost of Revenue | 97.09 Million | 3.88 Million | 3.02 Million | 53.03 Million | 38.71 Million | 18.36 Million |
| Gross Profit | -76.37 Million | -751 Thousand | 15.01 Million | -39.42 Million | -31.73 Million | -4.23 Million |
| Operating Expenses | 133.59 Million | 113.16 Million | 89.37 Million | 70.27 Million | 52.61 Million | 24.52 Million |
| Selling, General and Administrative Expenses | 36.49 Million | 32.9 Million | 28.01 Million | 17.23 Million | 13.89 Million | 6.16 Million |
| Research and Development Expenses | 97.09 Million | 80.25 Million | 61.36 Million | 53.03 Million | 38.71 Million | 18.36 Million |
| Other Expenses | - | 2.53 Million | 16 Thousand | -181 Thousand | -46 Thousand | -2000.00 |
| Cost and Expenses | 133.59 Million | 113.16 Million | 89.37 Million | 70.27 Million | 52.61 Million | 24.52 Million |
| Operating Income | -112.86 Million | -110.03 Million | -71.33 Million | -56.66 Million | -50.76 Million | -10.39 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -6.41 Million | -3.02 Million | -152 Thousand | 3.63 Million | 848 Thousand |
| Earnings before Tax | -100.83 Million | -107.49 Million | -71.31 Million | -56.69 Million | -49.3 Million | -9.55 Million |
| Net Income | -100.83 Million | -101.07 Million | -68.29 Million | -56.54 Million | -52.93 Million | -9.55 Million |
| Earnings Per Share Basic | -2.58 | -3.12 | -2.46 | -2.12 | -2.00 | -0.76 |
| Earnings Per Share Diluted | -2.58 | -3.12 | -2.46 | -2.12 | -2.00 | -0.76 |
| Weighted Average Shares Outstanding | 39.13 Million | 32.35 Million | 27.73 Million | 26.68 Million | 26.49 Million | 12.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.13 Million | 32.35 Million | 27.73 Million | 26.68 Million | 26.49 Million | 12.51 Million |
| Gross Margin | -3.69 | -0.24 | 0.83 | -2.90 | -4.54 | -0.30 |
| EBIT Margin | -5.17 | -35.17 | -3.95 | -4.06 | -5.65 | -0.69 |
| Profit Margin | -4.87 | -32.30 | -3.79 | -4.15 | -7.58 | -0.68 |
| EBITDA | -107.11 Million | -106.15 Million | -68.31 Million | -55.22 Million | -44.62 Million | -9.7 Million |
| Earnings Before Tax Margin | -5.45 | -35.17 | -3.95 | -4.16 | -7.27 | -0.74 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5000.00 | 28 Thousand | 20.72 Million | -19 Thousand | 20.2 Million | 239 Thousand |
| Cost of Revenue | 1.62 Million | 1.59 Million | 5.74 Million | 4.23 Million | 1.39 Million | 1.42 Million |
| Gross Profit | -1.61 Million | -1.56 Million | 14.97 Million | -4.25 Million | 18.8 Million | -1.18 Million |
| Operating Expenses | 40.83 Million | 36.57 Million | 127.84 Million | 36.63 Million | 34.17 Million | 32.37 Million |
| Selling, General and Administrative Expenses | 8.97 Million | 8.7 Million | - | 10.6 Million | 9.11 Million | 8.79 Million |
| Research and Development Expenses | 31.86 Million | 27.87 Million | - | 26.02 Million | 25.06 Million | 23.58 Million |
| Other Expenses | -45 Thousand | -10 Thousand | -181 Thousand | -11 Thousand | -158 Thousand | 2.52 Million |
| Cost and Expenses | 42.46 Million | 38.16 Million | 133.59 Million | 36.63 Million | 34.17 Million | 32.37 Million |
| Operating Income | -42.45 Million | -38.13 Million | -112.86 Million | -36.65 Million | -13.97 Million | -32.13 Million |
| Interest Expense | - | - | - | 1.41 Million | - | - |
| Income Tax Expense | - | -1.00 | 5.58 Million | 6.72 Million | -3.87 Million | -1.42 Million |
| Earnings before Tax | -34.95 Million | -32.4 Million | -100.83 Million | -32.28 Million | -10.25 Million | -29.61 Million |
| Net Income | -34.95 Million | -32.4 Million | -100.83 Million | -32.28 Million | -10.25 Million | -29.61 Million |
| Earnings Per Share Basic | -0.63 | -0.66 | - | -0.83 | -0.24 | -0.77 |
| Earnings Per Share Diluted | -0.63 | -0.66 | - | -0.83 | -0.24 | -0.77 |
| Weighted Average Shares Outstanding | 55.28 Million | 49.27 Million | 39.13 Million | 39.13 Million | 42.25 Million | 38.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.28 Million | 49.27 Million | 39.13 Million | 39.13 Million | 42.25 Million | 38.33 Million |
| Gross Margin | -323.80 | -55.93 | 0.72 | 223.95 | 0.93 | -4.97 |
| EBIT Margin | -8166.40 | -1305.07 | - | 1849.42 | -0.62 | -134.46 |
| Profit Margin | -6990.60 | -1157.18 | -4.87 | 1699.11 | -0.51 | -123.92 |
| EBITDA | -40.83 Million | -36.54 Million | - | -35.13 Million | -12.57 Million | -32.13 Million |
| Earnings Before Tax Margin | -8491.20 | -1362.00 | -5.45 | 1929.05 | -0.69 | -134.46 |
CLSC3
GUJGASLTD
BMO
NRXPW
PAA
3727